Shu Xiaokun, a prominent life scientist, is set to become the founding director of the Institute of Chemical and Open Biotechnology Research and Application at Fudan University. This new institute, launching this month, will explore exciting research at the crossroads of physics, chemistry, and biology. A key focus will be developing next-generation tools for distinguishing cellular functions and targeted cancer therapies.
Shu’s return to China comes after significant achievements in the U.S. Recently, he was appointed Herfindahl Endowed Chair at the University of California, San Francisco. During his academic journey in the U.S., he secured over $20 million in funding from the National Institutes of Health (NIH), highlighting his impact in the research community.
One notable achievement was receiving the NIH Director’s New Innovator Award in 2012, which came with a grant of $2.36 million. In 2019, his work earned him the Maximizing Investigators’ Research Award, valued at $5.91 million over five years. These accolades speak to his innovative approach and the high regard in which he is held in the scientific world.
Shu’s career began in 1996 when he studied theoretical physics at Sichuan University, later moving to Fudan University for his master’s. In 2003, he shifted to the U.S. for a PhD at the University of Oregon and transitioned to biophysics. His groundbreaking work on luminescence mechanisms of fluorescent proteins set a new standard in research.
During his postdoctoral studies, he collaborated with Nobel laureate Roger Yonchien Tsien at the University of California, San Diego. There, he developed an infrared fluorescent protein for imaging live animals, a significant advancement in biological research. His published findings in the journal Science reflect the innovative spirit that continues to drive his work today.
Shu’s research journey illustrates an important trend: the blending of disciplines. This interdisciplinary approach has allowed him to explore areas like protein engineering and drug discovery, igniting new possibilities in medical research.
According to a recent report from the National Science Foundation, interdisciplinary research is becoming crucial in tackling complex global challenges, from health crises to climate change. Shu’s work exemplifies this trend and shows how blending knowledge from different fields can lead to groundbreaking discoveries.
As he leads the new institute at Fudan University, many in the scientific community are excited about the potential collaborations and advancements in biotechnology. His journey from physics to life sciences is a testament to the evolving landscape of research, urging future generations of scientists to embrace diverse fields and innovative thinking.
Source link
Celebrated life scientist Shu Xiaokun leaves US after 20 years for Chinese university – VnExpress International
